SECTORAL ASSET MANAGEMENT INC Diversified Active

Location: Montreal, Quebec, Canada

CIK: 0001274413 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $143M (100.0% shares, 0.0% debt)

Holdings (82)

New Positions (15)

Increased Positions (17)

RCUS ARCUS BIOSCIENCES 2.4%
Value $3.418M (+230.1%) Shares 110,870 (+146.0%) Est. Cost Unrealized
AVBP ARRIVENT BIOPHARMA 1.9%
Value $2.746M (+281.2%) Shares 79,043 (+163.4%) Est. Cost Unrealized
DXCM DEXCOM INC 2.4%
Value $3.418M (+134.3%) Shares 50,756 (+118.5%) Est. Cost Unrealized
BNTX BIONTECH SE 2.7%
Value $3.896M (+90.5%) Shares 41,869 (+88.9%) Est. Cost Unrealized
TECX TECTONIC THERAPEUTIC 1.7%
Value $2.441M (+288.6%) Shares 71,009 (+272.6%) Est. Cost Unrealized
SMMT SUMMIT THERAPEUTICS 2.2%
Value $3.208M (+129.2%) Shares 220,180 (+216.3%) Est. Cost Unrealized
IMTX IMMATICS NV 1.6%
Value $2.279M (+228.9%) Shares 224,928 (+236.6%) Est. Cost Unrealized
ROIV ROIVANT SCIENCES LTD 1.5%
Value $2.162M (+112.8%) Shares 61,100 (+88.0%) Est. Cost Unrealized
INSM INSMED INC 1.7%
Value $2.475M (-26.8%) Shares 23,216 (+18.0%) Est. Cost Unrealized
CYTK CYTOKINETICS INC 1.0%
Value $1.391M (+155.4%) Shares 16,330 (+123.7%) Est. Cost Unrealized
IQV IQVIA HOLDINGS INC 1.5%
Value $2.096M (+48.0%) Shares 10,848 (+30.6%) Est. Cost Unrealized
BSX BOSTON SCIENTIFIC 1.1%
Value $1.551M (-29.0%) Shares 36,330 (+4.5%) Est. Cost Unrealized
SYK STRYKER CORP 1.6%
Value $2.249M (+16.5%) Shares 7,129 (+21.4%) Est. Cost Unrealized
COGT COGENT BIOSCIENCES 0.7%
Value $1.035M (+14.7%) Shares 26,740 (+20.8%) Est. Cost Unrealized
PTCT PTC THERAPEUTICS INC 0.4%
Value $609K (+18.3%) Shares 7,470 (+12.3%) Est. Cost Unrealized
ISRG INTUITIVE SURGIC INC 1.6%
Value $2.326M (-3.9%) Shares 5,850 (+11.4%) Est. Cost Unrealized
TARS TARSUS PHARMACEUTICALS 0.6%
Value $836K (-1.9%) Shares 13,285 (+17.9%) Est. Cost Unrealized

Decreased Positions (17)

GILD GILEAD SCIENCES INC 1.8%
Value $2.605M (-36.9%) Shares 20,620 (-25.0%) Est. Cost Unrealized
UNH UNITEDHEALTH GRP INC 3.8%
Value $5.501M (+35.9%) Shares 13,235 (-11.5%) Est. Cost Unrealized
REGN REGENERON PHARMCTCLS 0.9%
Value $1.352M (-45.5%) Shares 2,169 (-25.7%) Est. Cost Unrealized
ABT ABBOTT LABS 1.1%
Value $1.641M (-37.5%) Shares 18,080 (-29.3%) Est. Cost Unrealized
VRTX VERTEX PHARMA 1.9%
Value $2.698M (-22.0%) Shares 5,432 (-22.5%) Est. Cost Unrealized
MLYS MINERALYS THERAPEUTICS 0.3%
Value $393K (-56.1%) Shares 14,565 (-53.9%) Est. Cost Unrealized
GPCR STRUCTURE THERAPEUTICS 0.2%
Value $232K (-67.3%) Shares 4,325 (-69.3%) Est. Cost Unrealized
SNDX SYNDAX PHARMACEUTICS 0.2%
Value $343K (-56.5%) Shares 15,680 (-50.5%) Est. Cost Unrealized
SPRY ARS PHARMACEUTICALS 0.2%
Value $239K (-64.6%) Shares 29,900 (-62.2%) Est. Cost Unrealized
UTHR UNITED THERAPEUTICS 0.5%
Value $742K (-35.2%) Shares 1,370 (-19.9%) Est. Cost Unrealized
BBIO BRIDGEBIO PHARMA 0.2%
Value $305K (-55.6%) Shares 4,100 (-49.4%) Est. Cost Unrealized
TRVI TREVI THERAPEUTICS 0.9%
Value $1.223M (+30.2%) Shares 65,596 (-11.9%) Est. Cost Unrealized
HNGE HINGE HEALTH INC 0.5%
Value $726K (+53.7%) Shares 8,744 (-28.6%) Est. Cost Unrealized
NKTR NEKTAR THERAPEUTICS 0.5%
Value $706K (-14.0%) Shares 10,111 (-6.8%) Est. Cost Unrealized
ARGX ARGENX SE 1.8%
Value $2.627M (-4.0%) Shares 2,831 (-20.6%) Est. Cost Unrealized
PRVA PRIVIA HEALTH GROUP 0.4%
Value $621K (+11.3%) Shares 24,136 (-11.1%) Est. Cost Unrealized
EW EDWARDS LIFESCIENCES 0.9%
Value $1.341M (-3.4%) Shares 14,826 (-14.5%) Est. Cost Unrealized

Unchanged Positions (33)

SI SHOULDER INNOVATIONS 6.1%
Value $8.729M Shares 430,407 Est. Cost Unrealized
CTNM CONTINEUM THERAPEUTICS 8.3%
Value $11.93M Shares 727,587 Est. Cost Unrealized
LLY ELI LILLY & CO 5.3%
Value $7.621M Shares 6,354 Est. Cost Unrealized
ABBV ABBVIE INC 2.1%
Value $3.07M Shares 12,200 Est. Cost Unrealized
MRK MERCK & CO INC 1.9%
Value $2.773M Shares 21,480 Est. Cost Unrealized
AMGN AMGEN INC 2.3%
Value $3.335M Shares 9,210 Est. Cost Unrealized
KURA KURA ONCOLOGY INC 0.5%
Value $784K Shares 71,480 Est. Cost Unrealized
JNJ JOHNSON & JOHNSON 3.2%
Value $4.627M Shares 18,218 Est. Cost Unrealized
ALNY ALNYLAM PHARMACUETCL 0.5%
Value $695K Shares 2,310 Est. Cost Unrealized
ARDX ARDELYX INC 0.4%
Value $624K Shares 122,394 Est. Cost Unrealized
RVMD REVOLUTION MEDICINES 0.2%
Value $343K Shares 1,830 Est. Cost Unrealized
PFE PFIZER INC 0.5%
Value $662K Shares 27,500 Est. Cost Unrealized
ONC BEONE MEDICINES LTD 0.4%
Value $533K Shares 1,870 Est. Cost Unrealized
GH GUARDANT HEALTH INC 0.2%
Value $297K Shares 1,980 Est. Cost Unrealized
AGMB AGOMAB THERAPEUTICS 0.4%
Value $565K Shares 43,500 Est. Cost Unrealized
MDT MEDTRONIC PLC 0.6%
Value $876K Shares 11,100 Est. Cost Unrealized
ILMN ILLUMINA INC 0.3%
Value $375K Shares 2,132 Est. Cost Unrealized
ORIC ORIC PHARMACEUTICALS 0.2%
Value $255K Shares 23,500 Est. Cost Unrealized
AXSM AXSOME THERAPEUTIC 0.3%
Value $367K Shares 1,500 Est. Cost Unrealized
BMRN BIOMARIN PHARMAC 0.4%
Value $541K Shares 9,450 Est. Cost Unrealized
BMY BRISTOL MYERS SQUIBB 0.9%
Value $1.219M Shares 21,150 Est. Cost Unrealized
MRNA MODERNA INC 0.2%
Value $305K Shares 4,350 Est. Cost Unrealized
JAZZ JAZZ PHARMA PLC 0.3%
Value $422K Shares 1,750 Est. Cost Unrealized
IONS IONIS PHARMACEUTICAL 0.4%
Value $571K Shares 7,200 Est. Cost Unrealized
TMO THERMO FISHER SCIENTIFIC 1.2%
Value $1.76M Shares 3,508 Est. Cost Unrealized
ABVX ABIVAX SA 0.2%
Value $312K Shares 2,340 Est. Cost Unrealized
BIIB BIOGEN INC 0.3%
Value $400K Shares 1,850 Est. Cost Unrealized
VERA VERA THERAPEUTICS 0.8%
Value $1.097M Shares 25,573 Est. Cost Unrealized
INCY INCYTE CORPORATION 0.2%
Value $266K Shares 2,350 Est. Cost Unrealized
PALI PALISADE BIO INC 0.1%
Value $184K Shares 88,000 Est. Cost Unrealized
DHR DANAHER CORP 1.3%
Value $1.831M Shares 9,597 Est. Cost Unrealized
RPRX ROYALTY PHARMA PLC 0.3%
Value $404K Shares 7,200 Est. Cost Unrealized
MEDP MEDPACE HOLDINGS 0.2%
Value $228K Shares 430 Est. Cost Unrealized